Elevation Oncology, Inc. Quarterly Assets in USD from Q4 2020 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Elevation Oncology, Inc. quarterly Assets history and growth rate from Q4 2020 to Q3 2024.
Elevation Oncology, Inc. Assets for the quarter ending September 30, 2024 was $106M, a 6.33% increase year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$106M	+$6.33M	+6.33%	Sep 30, 2024	10-Q	2024-11-06
Q2 2024	$115M	+$4.23M	+3.83%	Jun 30, 2024	10-Q	2024-08-06
Q1 2024	$109M	+$32.1M	+41.7%	Mar 31, 2024	10-Q	2024-05-02
Q4 2023	$89.1M	-$5.07M	-5.38%	Dec 31, 2023	10-Q	2024-11-06
Q3 2023	$100M	-$11.5M	-10.3%	Sep 30, 2023	10-Q	2023-11-02
Q2 2023	$110M	-$13.4M	-10.8%	Jun 30, 2023	10-Q	2023-08-03
Q1 2023	$76.9M	-$57.4M	-42.7%	Mar 31, 2023	10-Q	2023-05-15
Q4 2022	$94.2M	-$55.3M	-37%	Dec 31, 2022	10-K	2024-03-06
Q3 2022	$111M	-$47M	-29.7%	Sep 30, 2022	10-Q	2022-11-03
Q2 2022	$124M	-$35.3M	-22.2%	Jun 30, 2022	10-Q	2022-08-04
Q1 2022	$134M			Mar 31, 2022	10-Q	2022-05-05
Q4 2021	$149M	+$68.6M	+84.8%	Dec 31, 2021	10-K	2023-03-09
Q3 2021	$159M			Sep 30, 2021	10-Q	2021-11-12
Q2 2021	$159M			Jun 30, 2021	10-Q	2021-08-12
Q4 2020	$80.9M			Dec 31, 2020	10-K	2022-03-03

* An asterisk sign (*) next to the value indicates that the value is likely invalid.